Sökresultat

The links below open on Lund University's Research Portal. Var god vänta...

https://www.iea.lth.se/publikationer - 2026-07-23

PostadressIndustriell elektroteknik och automation (IEA)Lunds Tekniska HögskolaBox 118, 221 00 LUNDBesöksadressIndustriell elektroteknik och automation (IEA)M-huset, Ole Römers väg 1, 223 62 LUNDLeveransadressIndustriell elektroteknik och automation (IEA)Lunds Tekniska HögskolaOle Römers väg 1A/B/C/D/E/F, 223 63 LUND E-post & telefon +46 46 222 92 90iea [at] iea [dot] lth [dot] se (iea[at]iea[dot]

https://www.iea.lth.se/kontakt - 2026-07-23

Welcome to the Department of Immunotechnology We conduct research in focus areas such as immuno-oncology, biomarkers and sensitisation, and collaborate with researchers and clinicians world-wide. More about the department Research Education Infrastructure CREATE Health Inaugurated in 2006 with a focus on precision medicine, CREATE Health is a strategic centre for translational research focusing on

https://www.immun.lth.se/start - 2026-07-23

The links on this page open in Lund University's Research Portal. Var god vänta... Immunotechnology in Lund University's Research Portal More on the department's research output, projects and infrastructure.

https://www.immun.lth.se/research/publications - 2026-07-23

One of the reasons why it is important to bring innovations to the citizens of the community is that it is unacceptable that it should take 17 years in funding for an innovation to reach patients and our focus was to reduce this to a minimum. Faster research results for the publicAt the Department of Immunotechnology, we have been working with this since 1983 when we scouted out our first company

https://www.immun.lth.se/research/innovations - 2026-07-23

Myeloid Biomarkers and Immunotherapy group Our research focuses on the role of myeloid cells within the tumour microenvironment and strategies to modulate their functional activities. Tumour-infiltrating myeloid cells represent a highly heterogeneous population, including distinct subtypes and cellular states of macrophages, dendritic cells, monocytes, and granulocytes. These cells exhibit diverse

https://www.immun.lth.se/research/research-groups/malin-lindstedt - 2026-07-23

Psychological resilience in cancer group Psychological resilience has significant implications for cancer patients, since highly resilient patients experience a better quality of life, less mental health problems, and a better treatment outcome, referring to the ability to handle trauma in life, such as a cancer diagnosis. However, the somatic background of psychological resilience is largely unex

https://www.immun.lth.se/research/research-groups/carl-borrebaeck - 2026-07-23

The SPOTLab group – Spatial profiling of tumour microenvironments Immunotherapy is transforming cancer care, still the response rate to available immunotherapeutic drugs remains poor for many cancers, due to the complexity and heterogeneity of the tumour microenvironment. Our lab focuses on exploration of tumour microenvironments through spatial omics and imaging, development of computational mode

https://www.immun.lth.se/research/research-groups/anna-sandstrom-gerdtsson - 2026-07-23

Immunotoxicity / skin sensitisation group Modern society relies on thousands of chemicals found in everyday products, yet for most of them we still know very little about their toxicity, especially their potential effects on the immune system. Chemicals, pharmaceuticals, and other materials can disturb immune function, a phenomenon known as immunotoxicity, which can increase susceptibility to dise

https://www.immun.lth.se/research/research-groups/kathrin-zeller - 2026-07-23

Molecular evolution group Our group mainly focuses on the use of human antibodies and human antibody technology. Our research has, in response to technological development in the field, evolved out from an initial cellular-based antibody technology focus towards implementation of molecular technologies to enable scientific discoveries. The research group has extended the utility of molecular tools

https://www.immun.lth.se/research/research-groups/mats-ohlin - 2026-07-23

Translational lymphoma group / Immuno-oncology Our research focuses on finding biological answers to clinically important questions involving improved diagnosis, stratification and treatment of patients with lymphoma. The main challenge to successfully treat cancer is the heterogeneity of the malignancy, and methods that capture that heterogeneity and provide information on variations in tumour-re

https://www.immun.lth.se/research/research-groups/sara-ek - 2026-07-23

Cancer proteomics group Our main research aim is to enable comprehensive proteome comparisons using liquid chromatography – mass spectrometry (LC-MS). To accomplish this, we develop new strategies and tools for analysis of MS data from different types of workflows. Depending on biological questions and sample types, we utilise data-dependent (DDA, shotgun proteomics), data-independent (DIA, SWATH)

https://www.immun.lth.se/research/research-groups/fredrik-levander - 2026-07-23

Translational cancer immunotherapy group Cancer will affect every second individual in the coming years. The focus of my research is to utilise the immune system to eradicate tumours, since unharnessing this system has shown tremendous effects for cancer therapy. Consequently, we identify and implement novel drug targets that enable the immune system to eradicate cancer cells so that more patients

https://www.immun.lth.se/research/research-groups/kristina-lundberg - 2026-07-23

The Department offers several courses and programs in the field of Immunotechnology and Biopharmaceuticals. Please find below more detailed information about the different courses and programmes on undergraduate and graduate level. Please find information about content, admission requirements and recommendations for different study programmes by following the course links.Undergraduate levelLinks

https://www.immun.lth.se/education - 2026-07-23

Eight research groups at the department cover a wide range of research topics with one common ground – their translational character. From drug discovery to high-end analysis of patient samples, the goal is to make the research findings applicable in everyday life. Carl BorrebaeckPsychological resilience in cancer Sara EkTranslational lymphoma group / Immuno-oncology Anna Sandström GerdtssonThe SP

https://www.immun.lth.se/research/research-groups - 2026-07-23

The focus of the research performed at the department involves various aspects of Immuno-oncology, Biomarkers and Sensitisation. These research areas represent an exceedingly developing field of biomedicine, which holds great promises for future possibilities for important areas of disease, such as cancer and allergy.The research focus is supported by a framework of vital, in-house technology plat

https://www.immun.lth.se/research - 2026-07-23

 Please wait...

https://www.immun.lth.se/staff - 2026-07-23

Antibodies@LTH Research infrastructure at the Department of Immunotechnology at the Faculty of Engineering of Lund University. The infrastructure integrates several technology-focused entities (U-READ, Flow@LTH, and SpatialOmics) within the department that focuses on antibodies, their development and use in high-end applications (Lund University's Research Portal). SpatialOmics@LU Core facility of

https://www.immun.lth.se/infrastructure - 2026-07-23

Future medicine and diagnostic tools depend on a deep understanding of cellular and molecular processes, and the capability to translate novel findings into solutions for defined clinical problems. At the Department of Immunotechnology, we apply such strategies to selected focus areas such as immuno-oncology, biomarker identification, immunotoxicology and sensitisation. Our activities include deve

https://www.immun.lth.se/node/51 - 2026-07-23

Management Head of DepartmentMalin Lindstedtmalin [dot] lindstedt [at] immun [dot] lth [dot] se (malin[dot]lindstedt[at]immun[dot]lth[dot]se)+46 46 222 92 56Deputy Head of DepartmentSara Eksara [dot] ek [at] immun [dot] lth [dot] se (sara[dot]ek[at]immun[dot]lth[dot]se)+46 70 839 00 59Director of Third Cycle EducationMats Ohlinmats [dot] ohlin [at] immun [dot] lth [dot] se (mats[dot]ohlin[at]immun

https://www.immun.lth.se/contact - 2026-07-23